Abstract:You have accessJournal of UrologyKidney Cancer: Advanced (including Drug Therapy) I (MP10)1 May 2024MP10-12 THE EFFICACY AND SAFETY OF NEOADJUVANT IMMUNOTHERAPY PLUS TKIS THERAPY IN PATIENTS WITH RENAL CELL CARCINOMA AND INFERIOR VENA CAVA THROMBUS AND ITS IMPACT ON ROBOT-ASSISTED SURGICAL OUTCOMES Yu Zhang, Min Lu, and LuLin Ma Yu ZhangYu Zhang , Min LuMin Lu , and LuLin MaLuLin Ma View All Author Informationhttps://doi.org/10.1097/01.JU.0001008588.39303.c9.12AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: To provide insight into the efficacy and safety of neoadjuvant anti-PD-1 plus Axitinib therapy in patients with clear cell renal cell carcinoma (ccRCC) and inferior vena cava (IVC) thrombus and to report the surgical outcomes. METHODS: We conducted a prospective registration cohort study since October 2021 and eligible patients received 3 cycles of immunotherapy and 8 weeks of axitinib. We reported the overall response rate (ORR) according to Response Evaluation Criteria in Solid Tumors (RECIST) criteria. Drug toxicity is assessed using the Common Terminology Criteria for Adverse Events (CTCAE) and complications using the Clavien-Dindo Classification system. In addition, we reported the robot-assisted surgical outcomes. RESULTS: Twenty-two patients received the neoadjuvant strategy followed by robotic surgery and 17 patients completed the whole cycle. Four patients interrupted neoadjuvant treatment due to elevated thyroid function and creatinine. The ORR of primary tumor and IVC thrombus was 50% and 41.7%, respectively. No radiographic degradation of IVC thrombus was found though the median length of thrombus reduction was 1.2 cm. The median reduction of primary tumor diameter and thrombus were 35.4% and 28.9%, respectively. The pathological complete response of primary tumor and IVC thrombus was 41.7% and 58.3%, respectively. The pathological partial response of primary tumor and IVC thrombus was 16.7% and 25%, respectively. The median operation time was 202 min and the median blood loss was 400 ml. Eight patients (36.4 %) received segmental resection of IVC thrombus due to extensive involvement of IVC wall and 4 patients (18.2%) had open conversion. CONCLUSIONS: Neoadjuvant anti-PD-1 plus TKIs therapy showed acceptable ORR and drug toxicity in clinical use and good response in pathological assessment. The discrepancy of neoadjuvant therapy efficacy between radiographic imaging and pathology in primary tumor and thrombus assessment should be further studied. Tissue edema and adhesion or IVC wall involvement due to neoadjuvant therapy may change the established surgical strategy. Download PPTDownload PPTDownload PPT Source of Funding: None © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e143 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Yu Zhang More articles by this author Min Lu More articles by this author LuLin Ma More articles by this author Expand All Advertisement PDF downloadLoading ...

A case report of robot-assisted radical nephrectomy and inferior vena cava thrombectomy in a patient with renal cell carcinoma after pembrolizumab and axitinib combination therapy

Sarcomatoid renal cell carcinoma with an inferior vena cava tumor thrombus that was completely resected by robot-assisted laparoscopic radical nephrectomy after neoadjuvant therapy nivolumab plus ipilimumab: a case report

Robot-assisted radical nephrectomy with inferior vena cava thrombectomy: a case report

Case Report: Robot-assisted Laparoscopic Partial Nephrectomy for Renal Cell Carcinoma in a Patient with Situs Inversus Totalis and Abdominal Cocoon

Advanced Renal Cell Carcinoma With Inferior Vena Cava Thrombus Treated With a Combination of Preoperative Lenvatinib and Pembrolizumab

[Presurgical Treatment with Axitinib and Pembrolizumab Reduced Operation Risk by Downsizing the Vena Cava Tumor Thrombus in Clear Cell Renal Cell Carcinoma : A Case Report]

A Narrative Review on Robotic Surgery as Treatment for Renal Cell Carcinoma with Inferior Vena Cava Thrombus

MP10-12 THE EFFICACY AND SAFETY OF NEOADJUVANT IMMUNOTHERAPY PLUS TKIS THERAPY IN PATIENTS WITH RENAL CELL CARCINOMA AND INFERIOR VENA CAVA THROMBUS AND ITS IMPACT ON ROBOT-ASSISTED SURGICAL OUTCOMES

Robot-assisted Partial Nephrectomy With Selective Artery Clamping for Renal Cell Carcinoma in Horseshoe Kidney

Stage IV renal cell carcinoma achieves pathologic complete response after two ipilimumab plus nivolumab courses despite severe immune-related adverse events: a case report

Avelumab plus Axitinib for the Treatment of Patients with End-Stage Renal Disease Undergoing Dialysis: A Retrospective Case Series and Literature Review

Resection of extensive segments of inferior vena cava without reconstruction in the treatment of renal carcinoma with inferior vena cava tumor thrombus: A case report

Efficacy of Nivolumab Plus Ipilimumab in a Patient With Renal Cell Carcinoma Concomitant With Cardiac Metastasis: A Case Report

Case report: Complete remission of bone metastasis from renal cell carcinoma in histopathological examination after treatment with immune checkpoint inhibitors

A safe and effective treatment combination of neoadjuvant therapy and surgical resection for metastatic TFE3-rearranged renal cell carcinoma:a case report

Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study

Therapeutic and Clinical Outcomes of Robot-assisted Partial Nephrectomy Versus Cryoablation for T1 Renal Cell Carcinoma

Comparative analysis of dual immune checkpoint inhibitor combination therapy versus immune checkpoint inhibitor plus tyrosine kinase inhibitor combination therapy for renal cell carcinoma with inferior vena cava tumor thrombosis

Robot-assisted radical nephroureterectomy for upper urinary tract tumor: initial experience with the use of novel surgical robot system, hinotori

Propensity score-matched analysis comparing robot-assisted partial nephrectomy and image-guided percutaneous cryoablation for cT1 renal cell carcinoma

Immune Checkpoint Inhibitor Therapy Before Nephrectomy for Locally Advanced and Metastatic Renal Cell Carcinoma: A Review